Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease
PEDIATRIC NEPHROLOGY, cilt.31, sa.2, ss.267-277, 2016 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 31 Sayı: 2
- Basım Tarihi: 2016
- Doi Numarası: 10.1007/s00467-015-3220-5
- Dergi Adı: PEDIATRIC NEPHROLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.267-277
- Anahtar Kelimeler: Chronic kidney disease, 25-hydroxyvitamin D3, Children, Flow-mediated dilatation, Arterial stiffness, VITAMIN-D DEFICIENCY, STAGE RENAL-DISEASE, LEFT-VENTRICULAR HYPERTROPHY, CARDIOVASCULAR MORTALITY, HEMODIALYSIS-PATIENTS, MINERAL METABOLISM, HYPERHOMOCYSTEINEMIA, DIALYSIS, IMPACT, ADULTS
- Kocaeli Üniversitesi Adresli: Evet
Özet
As cardiovascular factors are the leading cause of mortality in chronic kidney disease (CKD) and as vitamin D deficiency is prevalent in this population, we aimed to examine the effect of oral cholecalciferol on cardiac parameters and biomarkers for endothelial cell activation in children with CKD.